Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and NHG Health's Institute of Mental Health (IMH) have mapped how brain networks differ in ...

Challenges in clinical trials are unique to each therapeutic area, whether patient recruitment or regulatory compliance. For example, oncology trials require precise endpoint definitions, while ...

In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when ...